Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).

Market Analysis and Insights: Global Cyclospora Diagnostic Testing Market

The global Cyclospora Diagnostic Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Cyclospora Diagnostic Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cyclospora Diagnostic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cyclospora Diagnostic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cyclospora Diagnostic Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cyclospora Diagnostic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cyclospora Diagnostic Testing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cyclospora Diagnostic Testing Market Report

Report Metric	Details
Report Name	Cyclospora Diagnostic Testing Market
CAGR	5%
Segment by Type	Acid-fast Staining Safranin Staining
Segment by Application	Commercial or Private Laboratories Hospitals Public Health Labs Physician Offices
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Beckman Coulter, Inc, bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc, Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company), DiaSorin S.p.A., Roche Diagnostics (a division of Hoffmann-La Roche), Siemens Healthcare, QIAGEN N.V., Wako Chemicals USA, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cyclospora Diagnostic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyclospora Diagnostic Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyclospora Diagnostic Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Cyclospora Diagnostic Testing Market report?

Ans: The main players in the Cyclospora Diagnostic Testing Market are Thermo Fisher Scientific, Beckman Coulter, Inc, bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc, Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company), DiaSorin S.p.A., Roche Diagnostics (a division of Hoffmann-La Roche), Siemens Healthcare, QIAGEN N.V., Wako Chemicals USA, Inc.

What are the Application segmentation covered in the Cyclospora Diagnostic Testing Market report?

Ans: The Applications covered in the Cyclospora Diagnostic Testing Market report are Commercial or Private Laboratories, Hospitals, Public Health Labs, Physician Offices

What are the Type segmentation covered in the Cyclospora Diagnostic Testing Market report?

Ans: The Types covered in the Cyclospora Diagnostic Testing Market report are Acid-fast Staining, Safranin Staining

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Acid-fast Staining

1.2.3 Safranin Staining

1.3 Market by Application

1.3.1 Global Cyclospora Diagnostic Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Commercial or Private Laboratories

1.3.3 Hospitals

1.3.4 Public Health Labs

1.3.5 Physician Offices

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cyclospora Diagnostic Testing Market Perspective (2019-2030)

2.2 Global Cyclospora Diagnostic Testing Growth Trends by Region

2.2.1 Cyclospora Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cyclospora Diagnostic Testing Historic Market Size by Region (2019-2024)

2.2.3 Cyclospora Diagnostic Testing Forecasted Market Size by Region (2025-2030)

2.3 Cyclospora Diagnostic Testing Market Dynamics

2.3.1 Cyclospora Diagnostic Testing Industry Trends

2.3.2 Cyclospora Diagnostic Testing Market Drivers

2.3.3 Cyclospora Diagnostic Testing Market Challenges

2.3.4 Cyclospora Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cyclospora Diagnostic Testing by Players

3.1.1 Global Cyclospora Diagnostic Testing Revenue by Players (2019-2024)

3.1.2 Global Cyclospora Diagnostic Testing Revenue Market Share by Players (2019-2024)

3.2 Global Cyclospora Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cyclospora Diagnostic Testing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cyclospora Diagnostic Testing Market Concentration Ratio

3.4.1 Global Cyclospora Diagnostic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cyclospora Diagnostic Testing Revenue in 2023

3.5 Global Key Players of Cyclospora Diagnostic Testing Head office and Area Served

3.6 Global Key Players of Cyclospora Diagnostic Testing, Product and Application

3.7 Global Key Players of Cyclospora Diagnostic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cyclospora Diagnostic Testing Breakdown Data by Type

4.1 Global Cyclospora Diagnostic Testing Historic Market Size by Type (2019-2024)

4.2 Global Cyclospora Diagnostic Testing Forecasted Market Size by Type (2025-2030)

5 Cyclospora Diagnostic Testing Breakdown Data by Application

5.1 Global Cyclospora Diagnostic Testing Historic Market Size by Application (2019-2024)

5.2 Global Cyclospora Diagnostic Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cyclospora Diagnostic Testing Market Size (2019-2030)

6.2 North America Cyclospora Diagnostic Testing Market Size by Type

6.2.1 North America Cyclospora Diagnostic Testing Market Size by Type (2019-2024)

6.2.2 North America Cyclospora Diagnostic Testing Market Size by Type (2025-2030)

6.2.3 North America Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

6.3 North America Cyclospora Diagnostic Testing Market Size by Application

6.3.1 North America Cyclospora Diagnostic Testing Market Size by Application (2019-2024)

6.3.2 North America Cyclospora Diagnostic Testing Market Size by Application (2025-2030)

6.3.3 North America Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

6.4 North America Cyclospora Diagnostic Testing Market Size by Country

6.4.1 North America Cyclospora Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

6.4.3 North America Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cyclospora Diagnostic Testing Market Size (2019-2030)

7.2 Europe Cyclospora Diagnostic Testing Market Size by Type

7.2.1 Europe Cyclospora Diagnostic Testing Market Size by Type (2019-2024)

7.2.2 Europe Cyclospora Diagnostic Testing Market Size by Type (2025-2030)

7.2.3 Europe Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

7.3 Europe Cyclospora Diagnostic Testing Market Size by Application

7.3.1 Europe Cyclospora Diagnostic Testing Market Size by Application (2019-2024)

7.3.2 Europe Cyclospora Diagnostic Testing Market Size by Application (2025-2030)

7.3.3 Europe Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

7.4 Europe Cyclospora Diagnostic Testing Market Size by Country

7.4.1 Europe Cyclospora Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

7.4.3 Europe Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cyclospora Diagnostic Testing Market Size (2019-2030)

8.2 China Cyclospora Diagnostic Testing Market Size by Type

8.2.1 China Cyclospora Diagnostic Testing Market Size by Type (2019-2024)

8.2.2 China Cyclospora Diagnostic Testing Market Size by Type (2025-2030)

8.2.3 China Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

8.3 China Cyclospora Diagnostic Testing Market Size by Application

8.3.1 China Cyclospora Diagnostic Testing Market Size by Application (2019-2024)

8.3.2 China Cyclospora Diagnostic Testing Market Size by Application (2025-2030)

8.3.3 China Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cyclospora Diagnostic Testing Market Size (2019-2030)

9.2 Asia Cyclospora Diagnostic Testing Market Size by Type

9.2.1 Asia Cyclospora Diagnostic Testing Market Size by Type (2019-2024)

9.2.2 Asia Cyclospora Diagnostic Testing Market Size by Type (2025-2030)

9.2.3 Asia Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

9.3 Asia Cyclospora Diagnostic Testing Market Size by Application

9.3.1 Asia Cyclospora Diagnostic Testing Market Size by Application (2019-2024)

9.3.2 Asia Cyclospora Diagnostic Testing Market Size by Application (2025-2030)

9.3.3 Asia Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

9.4 Asia Cyclospora Diagnostic Testing Market Size by Region

9.4.1 Asia Cyclospora Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cyclospora Diagnostic Testing Market Size by Region (2019-2024)

9.4.3 Asia Cyclospora Diagnostic Testing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Cyclospora Diagnostic Testing Introduction

11.1.4 Thermo Fisher Scientific Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Developments

11.2 Beckman Coulter, Inc

11.2.1 Beckman Coulter, Inc Company Details

11.2.2 Beckman Coulter, Inc Business Overview

11.2.3 Beckman Coulter, Inc Cyclospora Diagnostic Testing Introduction

11.2.4 Beckman Coulter, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.2.5 Beckman Coulter, Inc Recent Developments

11.3 bioMerieux, Inc.

11.3.1 bioMerieux, Inc. Company Details

11.3.2 bioMerieux, Inc. Business Overview

11.3.3 bioMerieux, Inc. Cyclospora Diagnostic Testing Introduction

11.3.4 bioMerieux, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.3.5 bioMerieux, Inc. Recent Developments

11.4 CEPHEID

11.4.1 CEPHEID Company Details

11.4.2 CEPHEID Business Overview

11.4.3 CEPHEID Cyclospora Diagnostic Testing Introduction

11.4.4 CEPHEID Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.4.5 CEPHEID Recent Developments

11.5 Diamedix Corporation

11.5.1 Diamedix Corporation Company Details

11.5.2 Diamedix Corporation Business Overview

11.5.3 Diamedix Corporation Cyclospora Diagnostic Testing Introduction

11.5.4 Diamedix Corporation Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.5.5 Diamedix Corporation Recent Developments

11.6 Hologic, Inc

11.6.1 Hologic, Inc Company Details

11.6.2 Hologic, Inc Business Overview

11.6.3 Hologic, Inc Cyclospora Diagnostic Testing Introduction

11.6.4 Hologic, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.6.5 Hologic, Inc Recent Developments

11.7 Nanogen, Inc.

11.7.1 Nanogen, Inc. Company Details

11.7.2 Nanogen, Inc. Business Overview

11.7.3 Nanogen, Inc. Cyclospora Diagnostic Testing Introduction

11.7.4 Nanogen, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.7.5 Nanogen, Inc. Recent Developments

11.8 Ortho Clinical Diagnostics (a Johnson & Johnson company)

11.8.1 Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Details

11.8.2 Ortho Clinical Diagnostics (a Johnson & Johnson company) Business Overview

11.8.3 Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Introduction

11.8.4 Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.8.5 Ortho Clinical Diagnostics (a Johnson & Johnson company) Recent Developments

11.9 DiaSorin S.p.A.

11.9.1 DiaSorin S.p.A. Company Details

11.9.2 DiaSorin S.p.A. Business Overview

11.9.3 DiaSorin S.p.A. Cyclospora Diagnostic Testing Introduction

11.9.4 DiaSorin S.p.A. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.9.5 DiaSorin S.p.A. Recent Developments

11.10 Roche Diagnostics (a division of Hoffmann-La Roche)

11.10.1 Roche Diagnostics (a division of Hoffmann-La Roche) Company Details

11.10.2 Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview

11.10.3 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Introduction

11.10.4 Roche Diagnostics (a division of Hoffmann-La Roche) Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.10.5 Roche Diagnostics (a division of Hoffmann-La Roche) Recent Developments

11.11 Siemens Healthcare

11.11.1 Siemens Healthcare Company Details

11.11.2 Siemens Healthcare Business Overview

11.11.3 Siemens Healthcare Cyclospora Diagnostic Testing Introduction

11.11.4 Siemens Healthcare Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.11.5 Siemens Healthcare Recent Developments

11.12 QIAGEN N.V.

11.12.1 QIAGEN N.V. Company Details

11.12.2 QIAGEN N.V. Business Overview

11.12.3 QIAGEN N.V. Cyclospora Diagnostic Testing Introduction

11.12.4 QIAGEN N.V. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.12.5 QIAGEN N.V. Recent Developments

11.13 Wako Chemicals USA, Inc.

11.13.1 Wako Chemicals USA, Inc. Company Details

11.13.2 Wako Chemicals USA, Inc. Business Overview

11.13.3 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Introduction

11.13.4 Wako Chemicals USA, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.13.5 Wako Chemicals USA, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

Ortho Clinical Diagnostics (a Johnson & Johnson company)

DiaSorin

Siemens Healthcare

QIAGEN N V

Wako Chemicals USA, Inc.

List of Tables

Table 1. Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Acid-fast Staining

Table 3. Key Players of Safranin Staining

Table 4. Global Cyclospora Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Cyclospora Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cyclospora Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cyclospora Diagnostic Testing Market Share by Region (2019-2024)

Table 8. Global Cyclospora Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cyclospora Diagnostic Testing Market Share by Region (2025-2030)

Table 10. Cyclospora Diagnostic Testing Market Trends

Table 11. Cyclospora Diagnostic Testing Market Drivers

Table 12. Cyclospora Diagnostic Testing Market Challenges

Table 13. Cyclospora Diagnostic Testing Market Restraints

Table 14. Global Cyclospora Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cyclospora Diagnostic Testing Revenue Share by Players (2019-2024)

Table 16. Global Top Cyclospora Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclospora Diagnostic Testing as of 2023)

Table 17. Global Cyclospora Diagnostic Testing Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Cyclospora Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cyclospora Diagnostic Testing, Headquarters and Area Served

Table 20. Global Key Players of Cyclospora Diagnostic Testing, Product and Application

Table 21. Global Key Players of Cyclospora Diagnostic Testing, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2019-2024)

Table 25. Global Cyclospora Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2025-2030)

Table 27. Global Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cyclospora Diagnostic Testing Revenue Share by Application (2019-2024)

Table 29. Global Cyclospora Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cyclospora Diagnostic Testing Revenue Share by Application (2025-2030)

Table 31. North America Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Cyclospora Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Cyclospora Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Cyclospora Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Cyclospora Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Cyclospora Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Cyclospora Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Cyclospora Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Cyclospora Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Cyclospora Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Cyclospora Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Cyclospora Diagnostic Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Cyclospora Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Cyclospora Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 63. Thermo Fisher Scientific Company Details

Table 64. Thermo Fisher Scientific Business Overview

Table 65. Thermo Fisher Scientific Cyclospora Diagnostic Testing Product

Table 66. Thermo Fisher Scientific Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 67. Thermo Fisher Scientific Recent Developments

Table 68. Beckman Coulter, Inc Company Details

Table 69. Beckman Coulter, Inc Business Overview

Table 70. Beckman Coulter, Inc Cyclospora Diagnostic Testing Product

Table 71. Beckman Coulter, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 72. Beckman Coulter, Inc Recent Developments

Table 73. bioMerieux, Inc. Company Details

Table 74. bioMerieux, Inc. Business Overview

Table 75. bioMerieux, Inc. Cyclospora Diagnostic Testing Product

Table 76. bioMerieux, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 77. bioMerieux, Inc. Recent Developments

Table 78. CEPHEID Company Details

Table 79. CEPHEID Business Overview

Table 80. CEPHEID Cyclospora Diagnostic Testing Product

Table 81. CEPHEID Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 82. CEPHEID Recent Developments

Table 83. Diamedix Corporation Company Details

Table 84. Diamedix Corporation Business Overview

Table 85. Diamedix Corporation Cyclospora Diagnostic Testing Product

Table 86. Diamedix Corporation Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 87. Diamedix Corporation Recent Developments

Table 88. Hologic, Inc Company Details

Table 89. Hologic, Inc Business Overview

Table 90. Hologic, Inc Cyclospora Diagnostic Testing Product

Table 91. Hologic, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 92. Hologic, Inc Recent Developments

Table 93. Nanogen, Inc. Company Details

Table 94. Nanogen, Inc. Business Overview

Table 95. Nanogen, Inc. Cyclospora Diagnostic Testing Product

Table 96. Nanogen, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 97. Nanogen, Inc. Recent Developments

Table 98. Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Details

Table 99. Ortho Clinical Diagnostics (a Johnson & Johnson company) Business Overview

Table 100. Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Product

Table 101. Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 102. Ortho Clinical Diagnostics (a Johnson & Johnson company) Recent Developments

Table 103. DiaSorin S.p.A. Company Details

Table 104. DiaSorin S.p.A. Business Overview

Table 105. DiaSorin S.p.A. Cyclospora Diagnostic Testing Product

Table 106. DiaSorin S.p.A. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 107. DiaSorin S.p.A. Recent Developments

Table 108. Roche Diagnostics (a division of Hoffmann-La Roche) Company Details

Table 109. Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview

Table 110. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product

Table 111. Roche Diagnostics (a division of Hoffmann-La Roche) Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 112. Roche Diagnostics (a division of Hoffmann-La Roche) Recent Developments

Table 113. Siemens Healthcare Company Details

Table 114. Siemens Healthcare Business Overview

Table 115. Siemens Healthcare Cyclospora Diagnostic Testing Product

Table 116. Siemens Healthcare Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 117. Siemens Healthcare Recent Developments

Table 118. QIAGEN N.V. Company Details

Table 119. QIAGEN N.V. Business Overview

Table 120. QIAGEN N.V. Cyclospora Diagnostic Testing Product

Table 121. QIAGEN N.V. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 122. QIAGEN N.V. Recent Developments

Table 123. Wako Chemicals USA, Inc. Company Details

Table 124. Wako Chemicals USA, Inc. Business Overview

Table 125. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product

Table 126. Wako Chemicals USA, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 127. Wako Chemicals USA, Inc. Recent Developments

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cyclospora Diagnostic Testing Market Share by Type: 2023 VS 2030

Figure 3. Acid-fast Staining Features

Figure 4. Safranin Staining Features

Figure 5. Global Cyclospora Diagnostic Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Cyclospora Diagnostic Testing Market Share by Application: 2023 VS 2030

Figure 7. Commercial or Private Laboratories Case Studies

Figure 8. Hospitals Case Studies

Figure 9. Public Health Labs Case Studies

Figure 10. Physician Offices Case Studies

Figure 11. Cyclospora Diagnostic Testing Report Years Considered

Figure 12. Global Cyclospora Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cyclospora Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cyclospora Diagnostic Testing Market Share by Region: 2023 VS 2030

Figure 15. Global Cyclospora Diagnostic Testing Market Share by Players in 2023

Figure 16. Global Top Cyclospora Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclospora Diagnostic Testing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cyclospora Diagnostic Testing Revenue in 2023

Figure 18. North America Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

Figure 20. North America Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

Figure 21. North America Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 22. United States Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cyclospora Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

Figure 26. Europe Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

Figure 27. Europe Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 28. Germany Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Cyclospora Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

Figure 36. China Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

Figure 37. Asia Cyclospora Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

Figure 39. Asia Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

Figure 40. Asia Cyclospora Diagnostic Testing Market Share by Region (2019-2030)

Figure 41. Japan Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 51. Brazil Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 58. Beckman Coulter, Inc Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 59. bioMerieux, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 60. CEPHEID Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 61. Diamedix Corporation Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 62. Hologic, Inc Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 63. Nanogen, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 64. Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 65. DiaSorin S.p.A. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 66. Roche Diagnostics (a division of Hoffmann-La Roche) Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 67. Siemens Healthcare Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 68. QIAGEN N.V. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 69. Wako Chemicals USA, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions